Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
City of Hope Redefines Cancer Care with National Trials Model
Clinical & Pharma City of Hope Redefines Cancer Care with National Trials Model

In a remarkable leap forward for cancer treatment, City of Hope, a premier cancer research and treatment organization headquartered in Los Angeles, has unveiled a transformative national clinical trials model that could reshape the landscape of medical research in the United States. This

Strive Health Secures $550M for Kidney Care Innovation
Management & Administration Strive Health Secures $550M for Kidney Care Innovation

In a transformative moment for the healthcare sector, Strive Health, a pioneering company focused on value-based kidney care, has recently clinched a staggering $550 million in funding, blending $300 million from a Series D equity round with $250 million in debt financing. Established in 2018, this

Can a Community Cooperative Solve Wisconsin's Health Crisis?
Care Providers Can a Community Cooperative Solve Wisconsin's Health Crisis?

In the heart of western Wisconsin, particularly around Chippewa Falls and Eau Claire, a dire health care crisis has unfolded, leaving residents grappling with the fallout of multiple hospital closures and limited access to critical medical services. Sacred Heart Hospital in Eau Claire and St.

Wearable Injectors Revolutionize Drug Delivery Market
Tech & Innovation Wearable Injectors Revolutionize Drug Delivery Market

Imagine a world where managing chronic illnesses no longer means frequent hospital visits or cumbersome injections, but instead involves a discreet, wearable device that delivers life-sustaining medication seamlessly over hours or even days. Wearable injectors, innovative medical tools designed as

How Are Public Health Systems Failing Vulnerable Americans?
Clinical & Pharma How Are Public Health Systems Failing Vulnerable Americans?

In a nation often heralded for its advancements in medicine and technology, a troubling reality persists as public health systems struggle to protect those who need support the most, revealing deep flaws in the infrastructure meant to safeguard all citizens. Reports from experts, including seasoned

Why Sharing Research Results with Participants Matters
Clinical & Pharma Why Sharing Research Results with Participants Matters

In the intricate world of medical and health research, a quiet yet profound expectation lingers among those who volunteer their time, data, and even biological samples: the desire to know what their contributions have achieved, a yearning that underscores their role in advancing scientific

TNF Pharmaceuticals Pivots to Light-Based Blockchain Tech
Clinical & Pharma TNF Pharmaceuticals Pivots to Light-Based Blockchain Tech

In an unexpected turn of events that has captured the attention of both biotech and tech investors, TNF Pharmaceuticals, Inc. (NasdaTNFA), a company with deep roots in drug development, has embarked on a daring journey into the realm of photonic computing tailored for blockchain applications. This

Why Are Healthcare Costs Rising 8.4% and What Can HR Do?
Management & Administration Why Are Healthcare Costs Rising 8.4% and What Can HR Do?

As the calendar turns toward 2026, employers across the United States face a daunting financial challenge with healthcare costs projected to surge by 8.4%, impacting both medical and prescription drug expenses, and creating a significant burden for businesses. This increase translates into a

Why Is America’s Pharmaceutical Supply Chain in Crisis?
Management & Administration Why Is America’s Pharmaceutical Supply Chain in Crisis?

The United States stands at a critical juncture in its ability to secure essential medicines, grappling with a pharmaceutical supply chain crisis that threatens both national security and public health, a situation worsened by decades of increasing reliance on foreign manufacturing. Over the years,

Is the CDC Taking an Anti-Science Turn Under New Leadership?
Clinical & Pharma Is the CDC Taking an Anti-Science Turn Under New Leadership?

What happens when the cornerstone of public health in America, an agency millions rely on for life-saving guidance, begins to crumble under the weight of ideological battles? The Centers for Disease Control and Prevention (CDC), once a globally revered institution, now stands at a crossroads in

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later